Minerva Neurosciences, Inc. (NERV)
2.32
+0.08
(+3.57%)
USD |
NASDAQ |
Oct 30, 16:00
2.30
-0.02
(-0.86%)
After-Hours: 20:00
Minerva Neurosciences Debt to Equity Ratio : -0.3363 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3363 |
| March 31, 2026 | -0.2557 |
| December 31, 2025 | -0.4615 |
| September 30, 2025 | -1.735 |
| June 30, 2025 | -1.869 |
| March 31, 2025 | -2.058 |
| December 31, 2024 | -2.335 |
| September 30, 2024 | -2.769 |
| June 30, 2024 | -1.946 |
| March 31, 2024 | -2.303 |
| December 31, 2023 | -2.882 |
| September 30, 2023 | -3.982 |
| June 30, 2023 | -6.214 |
| March 31, 2023 | -2.844 |
| December 31, 2022 | -3.682 |
| September 30, 2022 | -5.041 |
| June 30, 2022 | -8.343 |
| March 31, 2022 | -92.52 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0005 |
| March 31, 2021 | 0.0014 |
| December 31, 2020 | 0.0021 |
| September 30, 2020 | 0.0027 |
| June 30, 2020 | 0.0035 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0131 |
| December 31, 2019 | 0.0102 |
| September 30, 2019 | 0.0058 |
| June 30, 2019 | 0.0054 |
| March 31, 2019 | 0.0052 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.0126 |
| March 31, 2018 | 0.0222 |
| December 31, 2017 | 0.0301 |
| September 30, 2017 | 0.0399 |
| June 30, 2017 | 0.0652 |
| March 31, 2017 | 0.0711 |
| December 31, 2016 | 0.082 |
| September 30, 2016 | 0.0866 |
| June 30, 2016 | 0.0838 |
| March 31, 2016 | 0.1503 |
| December 31, 2015 | 0.1796 |
| September 30, 2015 | 0.1563 |
| June 30, 2015 | 0.1431 |
| March 31, 2015 | 0.1304 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.116 |
| March 31, 2014 | 0.0246 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Heron Therapeutics, Inc. | 21.48 |
| Tonix Pharmaceuticals Holding Corp. | 0.0057 |
| Karyopharm Therapeutics, Inc. | -0.7759 |
| Corbus Pharmaceuticals Holdings, Inc. | 0.0417 |
| Ocugen, Inc. | -5.314 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 95.09M |
| Total Liabilities (Quarterly) | 308.39M |
| Shareholders Equity (Quarterly) | -213.30M |
| Current Ratio | 20.14 |
| Net Debt Paydown Yield | -0.90% |